BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26199176)

  • 1. Outcomes of squamous histology in bladder cancer: a population-based study.
    Izard JP; Siemens DR; Mackillop WJ; Wei X; Leveridge MJ; Berman DM; Peng Y; Booth CM
    Urol Oncol; 2015 Oct; 33(10):425.e7-13. PubMed ID: 26199176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Significance of Squamous Histology on Clinical Outcomes and PD-L1 Expression in Bladder Cancer.
    Gordetsky JB; Montgomery KW; Giannico GA; Rais-Bahrami S; Thapa P; Boorjian S; Frank I; Cheville J
    Int J Surg Pathol; 2022 Feb; 30(1):6-14. PubMed ID: 34180731
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.
    Minato A; Noguchi H; Tomisaki I; Fukuda A; Kubo T; Nakayama T; Fujimoto N
    Cancer Control; 2018; 25(1):1073274818800269. PubMed ID: 30213195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of squamous histology on survival in patients with muscle-invasive bladder cancer.
    Matulay JT; Woldu SL; Lim A; Narayan VM; Li G; Kamat AM; Anderson CB
    Urol Oncol; 2019 Jun; 37(6):353.e17-353.e24. PubMed ID: 30704959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
    Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
    J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of pretreatment inflammatory markers in variant histologies of the bladder: is inflammation linked to survival after radical cystectomy?
    Rodler S; Buchner A; Ledderose ST; Eismann L; Volz Y; Pfitzinger P; Kretschmer A; Schulz GB; Karl A; Schlenker B; Stief CG; Jokisch F
    World J Urol; 2021 Jul; 39(7):2537-2543. PubMed ID: 33084922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
    Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
    BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of apoptotic markers in squamous cell carcinoma of the urinary bladder.
    Youssef R; Kapur P; Shariat SF; Arendt T; Kabbani W; Mosbah A; Abol-Enein H; Ghoneim M; Lotan Y
    BJU Int; 2012 Oct; 110(7):961-6. PubMed ID: 22372762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of squamous cell transformation on the prognosis of patients treated with radical nephroureterectomy.
    Huang LH; Chen CS; Li JR; Chiu KY; Wang SS; Yang CK; Cheng CL; Lin CC; Ou YC
    BMC Cancer; 2024 Feb; 24(1):247. PubMed ID: 38388388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.
    Mitra AP; Bartsch CC; Bartsch G; Miranda G; Skinner EC; Daneshmand S
    Urol Oncol; 2014 Feb; 32(2):117-27. PubMed ID: 23477878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis.
    Abdollah F; Sun M; Jeldres C; Schmitges J; Thuret R; Djahangirian O; Tian Z; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    BJU Int; 2012 Feb; 109(4):564-9. PubMed ID: 21810161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological factors associated with survival benefit from adjuvant chemotherapy (ACT): a population-based study of bladder cancer.
    Booth CM; Siemens DR; Wei X; Peng Y; Berman DM; Mackillop WJ
    BJU Int; 2015 Sep; 116(3):373-81. PubMed ID: 25168574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.
    Lughezzani G; Sun M; Jeldres C; Alasker A; Budäus L; Shariat SF; Latour M; Widmer H; Duclos A; Jolivet-Tremblay M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Feb; 75(2):376-81. PubMed ID: 20022091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort.
    Martin JW; Vernez SL; Lotan Y; Abdelhalim A; Dutta R; Shokeir A; Abol-Enein H; Mosbah A; Ghoneim M; Youssef RF
    World J Urol; 2018 Nov; 36(11):1835-1843. PubMed ID: 29761225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy.
    Fairey AS; Daneshmand S; Wang L; Schuckman A; Lieskovsky G; Djaladat H; Cai J; Miranda G; Skinner EC
    Urol Oncol; 2014 Feb; 32(2):110-6. PubMed ID: 23499168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do pure squamous cell carcinomas and urothelial carcinomas have similar prognosis after radical cystectomy?
    Balci U; Ozer K; Gorgel SN; Sefik E; Girgin C; Dincel C
    World J Urol; 2013 Oct; 31(5):1177-82. PubMed ID: 22544338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
    Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
    BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sociodemographic and survival disparities for histologic variants of bladder cancer.
    Jue JS; Koru-Sengul T; Moore KJ; Miao F; Alameddine M; Nahar B; Punnen S; Parekh DJ; Ritch CR; Gonzalgo ML
    Can J Urol; 2018 Feb; 25(1):9179-9185. PubMed ID: 29524972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: results from the Canadian Bladder Cancer Network Database.
    Fairey AS; Kassouf W; Aprikian AG; Chin JL; Izawa JI; Fradet Y; Lacombe L; Rendon RA; Bell D; Cagiannos I; Drachenberg DE; Lattouf JB; Estey EP
    Urol Oncol; 2012; 30(6):825-32. PubMed ID: 21889368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
    Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
    Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.